Kwee Ivo, PhD

Publications -> 18638

• The first‐in‐class ETS inhibitor TK‐216 interferes with ETS transcription factors and synergize with lenalidomide in lymphoma
  Spriano, F. Chung,E. Napoli, S. Gaudio, E. Cascione, L. Cavalli, A. Rinaldi, A. Kwee, I. Ye, H. Rossi, D. Zucca, E. Stathis, A. Jessen, K. Lannutti, B. Toretsky, J. Bertoni, F.
  in Hematological Oncology (2019) Vol.37 pp322
  
• The contribution of active and passive mechanisms of 5mC and 5hmC removal in human T lymphocytes is differentiation- and activation-dependent
  Vincenzetti, L. Leoni, C. Chirichella, M. Monticelli, S.
  in Eur J Immunol (2019) Vol.49 pp611-625